For R&D scientists and chemists in the pharmaceutical industry, identifying and procuring the right chemical building blocks is crucial for the successful development of new drugs. 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, identified by its CAS number 93107-30-3, is a prime example of such a critical intermediate. Its unique structural features make it an indispensable component in the synthesis of advanced antibacterial agents, particularly within the fluoroquinolone class.

The chemical structure of CAS 93107-30-3 is a complex fusion of a quinoline ring system, substituted with a cyclopropyl group at the N1 position and two fluorine atoms at the 6 and 7 positions, along with a carboxylic acid functional group. This specific arrangement of atoms is what bestows upon it the capability to serve as a precursor for potent antibacterial compounds, such as Moxifloxacin. The high purity of this intermediate, typically above 98% as determined by HPLC, is essential for ensuring the desired therapeutic outcomes and minimizing potential side effects in the final drug product. Its physical characteristics usually include being a solid, with a melting point reported around 289°C (lit.), indicating a stable chemical entity.

The primary application of 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid lies in its role as a key intermediate in the synthesis of fluoroquinolone antibiotics. These antibiotics are vital for treating a wide range of bacterial infections, and their efficacy depends on precise molecular architecture. Therefore, when researchers require this compound for their synthesis projects, they must ensure they purchase from reliable manufacturers and suppliers. Companies that specialize in fine chemicals and pharmaceutical intermediates, particularly those based in China, are often key sources, offering high-quality materials at competitive prices. A good supplier will provide comprehensive technical data and support.

For R&D scientists, understanding the sourcing landscape is as important as understanding the molecule itself. Access to consistent quality, timely delivery, and clear communication from suppliers are critical factors that can significantly impact research timelines. When selecting a supplier for CAS 93107-30-3, consider their track record, their commitment to quality assurance, and their ability to provide batch-to-batch consistency. This diligence ensures that your research and development efforts are built on a solid foundation.

In conclusion, 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (CAS 93107-30-3) is a cornerstone intermediate in the pharmaceutical synthesis of advanced antibacterial drugs. Its precise chemical structure and high purity are critical for the efficacy of the final APIs. For R&D scientists and procurement professionals seeking to buy this compound, prioritizing quality and reliability from experienced manufacturers and suppliers is key to driving successful drug development.